Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2020 02:00 ET | Source: Quantum Genomics

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Xediton Pharmaceuticals

Quantum Genomics to receive up to $11.35 million in upfront and milestone payments plus double-digit royalties on sales Xediton Pharmaceuticals to receive an exclusive license to develop and...
October 19, 2020 02:00 ET | Source: Quantum Genomics

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical

Quantum Genomics to receive up to $50 million in upfront and milestone payments plus double-digit royalties on sales Qilu Pharmaceutical to receive an exclusive license to develop and commercialize...
September 22, 2020 12:00 ET | Source: Quantum Genomics

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Orient EuroPharma (OEP)

Quantum Genomics to receive up to $19 million in upfront and milestone payments plus double-digit royalties on sales OEP to receive an exclusive license to develop and commercialize firibastat for...
July 13, 2020 02:00 ET | Source: Quantum Genomics

Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension

PARIS and NEW YORK, July 13, 2020 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly...
May 06, 2020 12:00 ET | Source: Quantum Genomics

Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients

PARIS and NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly...
April 07, 2020 12:00 ET | Source: Quantum Genomics

Quantum Genomics Provides Update on the Impact of the COVID-19 Health Crisis on Clinical Research Activities

PARIS and NEW YORK, April 07, 2020 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that...
March 31, 2020 09:52 ET | Source: Quantum Genomics

Quantum Genomics Secured New Financing, Published its Financial Statements for Fiscal Year 2019 and Provides 2019 Highlights

Despite the current public health crisis and any financial consequences it may have, the fact that Quantum Genomics has secured new financing confirms that investors remain confident in its outlook....
January 28, 2020 01:30 ET | Source: Quantum Genomics

Quantum Genomics Appoints Benoît Gueugnon as Vice President of Finance

PARIS and NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC, OTCQX - QNNTF), a biopharmaceutical company specializing in developing a new drug...
January 15, 2020 12:00 ET | Source: Quantum Genomics

Quantum Genomics to Present at the Gordon Research Conference 2020 Dedicated to the Renin Angiotensin Aldosterone System

PARIS and NEW YORK, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC, OTCQX - QNNTF), a biopharmaceutical company specializing in developing a new drug...
December 19, 2019 12:00 ET | Source: Quantum Genomics

Quantum Genomics Initiates its Pivotal Phase III FRESH Trial in Difficult-to-Treat and Resistant Hypertension

PARIS and NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC, OTCQX - QNNTF), a biopharmaceutical company specializing in developing a new drug...